William J. Barendt
University of Bristol(GB)AstraZeneca (Netherlands)(NL)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, 3D Printing in Biomedical Research
Most-Cited Works
- → Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics(2018)330 cited
- → Drug Sensitivity Assays of Human Cancer Organoid Cultures(2016)81 cited
- → A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates(2020)28 cited
- → Investigating the response of paediatric leukaemia‐propagating cells to BCL‐2 inhibitors(2020)5 cited
- → Erratum to: Drug Sensitivity Assays of Human Cancer Organoid Cultures(2018)3 cited
- → Combining BCL-2 Inhibitors with Parthenolide to Treat Childhood Acute Lymphoblastic Leukaemia(2015)3 cited
- → Towards the next-generation of cancer cell lines: Derivation of an organoid biobank(2016)
- → Drug Sensitivity Assays of Human Cancer Organoid Cultures v1(2020)
- → Author response: A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates(2020)